ERIKA DE REYNOSA, S.A. DE C.V. COMBISET SMARTECH BLOODLINE; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
|
Back to Search Results |
|
Catalog Number 03-2722-9C |
Device Problem
Fluid/Blood Leak (1250)
|
Patient Problems
Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914)
|
Event Date 07/07/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
|
|
Event Description
|
A user facility clinic manager (cm) reported to fresenius that a blood leak occurred with the combiset smartech bloodlines.Additional information was provided during follow-up by a user facility registered nurse (rn).The patient had approximately 45 minutes of left of hemodialysis (hd) treatment (out of a 3.5 hour runtime) when the reported event occurred.A slow drip of blood was observed around the arterial connection to the dialyzer.The connection was tightened however the leak continued from the crit-line window.When attempting to remove the crit-line clip (clic) device, the connection snapped in half.Treatment was paused.The patient¿s blood could not be returned.The patient¿s estimated blood loss (ebl) is approximately 350 ml.The rn noted that the patient experienced a drop in blood pressure from the blood loss.The rn explained that the patient¿s blood pressure normally runs high, and the clinic has standing order in place to all patients to provide 200 ml of saline intravenously (iv) when a drop in blood pressure is experienced which was used in this case.The rn confirmed that the patient did not experience a serious injury or require medical intervention as a result of this issue.The patient ended treatment for the day with approximately 45 minutes of runtime remaining.There was no observed defect or damage noted to the bloodline prior to the reported issue.The rn confirmed the sample has been discarded and is not available to be returned to the manufacturer for physical evaluation.
|
|
Manufacturer Narrative
|
Correction: d4 (expiration date), h4 plant investigation: as the device was not returned to the manufacturer, a physical evaluation could not be performed.A batch records review was conducted by the manufacturer for the reported lot.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.The entire lot has been sold and distributed.In addition, a device history review was performed and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The lot met all specifications for release.A product history review did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
|
|
Event Description
|
A user facility clinic manager (cm) reported to fresenius that a blood leak occurred with the combiset smartech bloodlines.Additional information was provided during follow-up by a user facility registered nurse (rn).The patient had approximately 45 minutes of left of hemodialysis (hd) treatment (out of a 3.5 hour runtime) when the reported event occurred.A slow drip of blood was observed around the arterial connection to the dialyzer.The connection was tightened however the leak continued from the crit-line window.When attempting to remove the crit-line clip (clic) device, the connection snapped in half.Treatment was paused.The patient¿s blood could not be returned.The patient¿s estimated blood loss (ebl) is approximately 350 ml.The rn noted that the patient experienced a drop in blood pressure from the blood loss.The rn explained that the patient¿s blood pressure normally runs high, and the clinic has standing order in place to all patients to provide 200 ml of saline intravenously (iv) when a drop in blood pressure is experienced which was used in this case.The rn confirmed that the patient did not experience a serious injury or require medical intervention as a result of this issue.The patient ended treatment for the day with approximately 45 minutes of runtime remaining.There was no observed defect or damage noted to the bloodline prior to the reported issue.The rn confirmed the sample has been discarded and is not available to be returned to the manufacturer for physical evaluation.
|
|
Search Alerts/Recalls
|
|
|